Subtype
Digestive System Adenocarcinoma
CI-CAN-00002525Explore in graph →
1,373 active trials24 approved drugs77 evidence items
- NCIt
- C210140
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002525Explore in graph →
Clinical trials
5,067 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (618)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00843934 | Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma(ACE500) | unknown | Phase 2 / Phase 3 | 450 | Nihon UniversityOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER |
| 1 |
| Oct 16, 2012 |
| clinicaltrials |
| NCT00522405 | Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma | unknown | Phase 2 / Phase 3 | — | All India Institute of Medical SciencesOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01438450 | Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma(OTCHCC) | unknown | Phase 2 / Phase 3 | 74 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01583361 | SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer(RESONANCE) | unknown | Phase 3 | 772 | Lin ChenOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT01489566 | Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients | unknown | Phase 3 | 300 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 14, 2011 | clinicaltrials |
| NCT01214343 | Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC | unknown | Phase 3 | 190 | Ministry of Health, Labour and Welfare, JapanOTHER_GOV | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00921531 | Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma | unknown | Phase 3 | 200 | Fudan UniversityOTHER | 1 | Apr 19, 2011 | clinicaltrials |
| NCT00501813 | Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion(MDTforHCC) | unknown | Phase 3 | 160 | Sun Yat-sen UniversityOTHER | 1 | Jul 30, 2010 | clinicaltrials |
| NCT00561522 | Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection | unknown | Phase 2 / Phase 3 | 290 | Fudan UniversityOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00728078 | Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma(LDT-RFA) | unknown | Phase 2 / Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00554125 | Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Nov 6, 2007 | clinicaltrials |
| NCT00460681 | Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Oct 31, 2007 | clinicaltrials |
| NCT00121914 | Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone | unknown | Phase 3 | 120 | Medical University of ViennaOTHER | 1 | Oct 18, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Oct 19, 2012source: clinicaltrials